Dr. Patrick D. Pfizenmayer, MD

Dr. Pfizenmayer practices at Doctors Medical Center of Modesto in Modesto, California.

Dr. Pfizenmayer's NPI, 1417434077, was assigned on July 25, 2018. Dr. Pfizenmayer graduated from Renaissance School of Medicine at Stony Brook University in 2016. Dr. Pfizenmayer's North Dakota license number on file is PT19648.

Dr. Pfizenmayer's primary practice is Doctors Medical Center of Modesto, at 1541 Florida Ave, Modesto, CA 95350 in Stanislaus County. The practice phone is (209) 578-1211.

Dr. Pfizenmayer's primary practice is Doctors Medical Center of Modesto in Modesto, California. The medical group on file is Greater Modesto Medical Surgical Associates. Dmand AI also links Dr. Pfizenmayer to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pfizenmayer practices. Vendor and product names are available with a free account.

Urology is Dr. Pfizenmayer's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Pfizenmayer's licenses on file in 3 states: North Dakota, California and New Jersey.

CMS data shows 740 Medicare services from Dr. Pfizenmayer across 15 procedure codes in 2024, for 289 Medicare patients. Medicare paid $48,822 for them.

CMS counts 289 Medicare patients who saw Dr. Pfizenmayer in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pfizenmayer's median patient age at 73, with 15% women.

In 2024, Dr. Pfizenmayer wrote 1,505 Medicare Part D claims for 297 patients. 89% of them were for generic drugs. CMS names the drug for 1,420 of them, across 15 drugs with 11 or more claims each, at $81,518 in total drug cost. In 2023, CMS named 45 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Pfizenmayer for performance year 2024, reported as part of a group.

CMS Open Payments shows 4 general payments to Dr. Pfizenmayer from 3 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $128.

Dr. Pfizenmayer graduated from Renaissance School of Medicine at Stony Brook University in 2016.

Dr. Pfizenmayer is in network with 6 carriers, including Blue Cross Blue Shield of North Dakota, Humana and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.